P755: HYPERFERRITINEMIA IS A PREDICTIVE BIOMARKER OF POOR CLINICAL OUTCOMES IN CMML

• L. E. Aguirre,
• S. Ball,
• A. Jain,
• N. Al Ali,
• D. Sallman,
• A. Kuykendall,
• K. Sweet,
• J. Lancet,
• E. Padron,
• R. Komrokji

Affiliations

L. E. Aguirre

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America

S. Ball

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America

A. Jain

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America

N. Al Ali

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America

D. Sallman

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America

A. Kuykendall

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America

K. Sweet

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America

J. Lancet

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America

E. Padron

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America

R. Komrokji

1 Malignant Hematology, Moffitt Cancer Center, Tampa, United States of America